Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Middle East respiratory syndrome coronavirus (MERS-CoV) is an emerging zoonotic coronavirus. First identified in 2012, MERS-CoV has caused over 2460 infections and a fatality rate of about 35% in humans. Similar to severe acute respiratory syndrome coronavirus (SARS-CoV), MERS-CoV likely originated from bats; however, different from SARS-CoV, which potentially utilized palm civets as its intermediate hosts, MERS-CoV likely transmits to humans through dromedary camels. Animal models, such as humanized mice and nonhuman primates, have been developed for studying MERS-CoV infection. Currently, there are no vaccines and therapeutics approved for the prevention and treatment of MERS-CoV infection, although a number of them have been developed preclinically or tested clinically. This book covers one editorial and 16 articles (including seven review articles and nine original research papers) written by researchers working in the field of MERS-CoV. It describes the following three main aspects: (1) MERS-CoV epidemiology, transmission, and pathogenesis; (2) current progress on MERS-CoV animal models, vaccines, and therapeutics; and (3) challenges and future prospects for MERS-CoV research. Overall, this book will help researchers in the MERS-CoV field to further advance their work on the virus. It also has important implications for other coronaviruses as well as viruses outside the coronavirus family with pandemic potentials.

cell–cell fusion --- hDPP4 --- n/a --- therapeutics --- animal models --- HCoV-229E --- Drivers --- camels --- rabbits --- SARS-CoV --- MERS-CoV --- MVA vaccine --- transmission --- RBD --- MERS-CoV nucleocapsid protein --- complement --- animal model --- pseudotyped virus --- combination --- MERS-coronavirus --- peptide --- mouse model --- spike protein --- receptor-binding domain --- prevention and treatment --- coronaviruses --- coronavirus spike glycoprotein --- therapeutic antibodies --- vaccine platforms --- mutation --- severe acute respiratory syndrome coronavirus --- pathogenesis --- fusion inhibitor --- Coronavirus --- murine CD8+ T cell epitope --- lipidomics --- authentic virus --- correlates of immunity --- vaccines --- neutralizing monoclonal antibodies --- Middle East respiratory syndrome coronavirus --- small-molecule inhibitor --- Middle East Respiratory Syndrome Virus --- DPP4 --- pyroptosis --- cross-neutralization --- inflammation --- Qatar --- spike proteins --- One Health --- HKU4 --- nanobodies --- mechanism of action --- neutralizing antibody --- host factors --- UHPLC–MS

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Phages have shown a high biotechnological potential with numerous applications. The advent of high-resolution microscopy techniques aligned with omic and molecular tools have revealed innovative phage features and enabled new processes that can be further exploited for biotechnological applications in a wide variety of fields. The high-quality original articles and reviews presented in this Special Issue demonstrate the incredible potential of phages and their derived proteins in a wide range of biotechnological applications for human benefit. Considering the emergence of amazing new available bioengineering tools and the high abundance of phages and the multitude of phage proteins yet to be discovered and studied, we believe that the upcoming years will present us with many more fascinating and new previously unimagined phage-based biotechnological applications.

toxicity --- encapsulation --- n/a --- cancerous tumors --- bacteriophage-derived lytic enzyme --- native gel electrophoresis --- bacteriophages --- Cpl-1 --- O-antigen --- ESKAPE --- Clostridium perfringens --- X-ray crystallography --- macromolecular interactions --- safety --- biofilm --- major coat protein --- Streptococcus agalactiae --- Staphylococcus aureus --- tail sheath protein --- magnetic separation --- serotyping --- pathogenic viruses --- liposomes --- tuberculosis --- Listeria monocytogenes --- nanotubular structures --- alpha-sheet --- biosensors --- sarcoidosis --- tailspike proteins --- M13 bacteriophage --- Streptococcus pneumoniae --- gene expression regulation --- bacteriophage recombination --- self-assembly --- phage therapy --- R-type pyocin --- contractile injection systems --- bacteriophage vB_EcoM_FV3 --- microtiter plate assay --- Enterococcus faecalis --- culture enrichment --- drug delivery vehicles --- neurodegenerative disease --- landscape phage --- niosomes --- bacteriophage --- Myoviridae --- bacteriophage evolution --- porous structure --- phage-host interaction --- phage display --- immune response --- antibiotic resistance --- Pseudomonas aeruginosa --- phage --- bacteriocin --- Appelmans --- fluorescence sensor --- molecular probe --- nanomedicine --- Shigella flexneri --- reporter phage --- filters --- in vitro activity --- capsid dynamics --- immunoscreening --- diagnostics --- microarray --- receptor-binding protein --- endolysin --- enzybiotics --- transfersomes --- T7phage library --- Pal